Zusammenfassung
Eine 49-jährige Patientin mit gerade diagnostiziertem Typ-2-Diabetes, Hyperlipidämie und Hypertonie, versucht durch Sport, Gewichtsabnahme, Zimt, Artischockenpräparate und Meditation ihr kardiovaskuläres Risiko zu senken. Was ist gesichert?
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
ADA (2012) Executive summary: Standards of medical care in diabetes – 2012. Diabetes Care 35(Suppl 1):4–10
Alexander CN, Langer EJ, Newman RI, Chandler HM et al (1989) Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol 57:950–964
Boule NG, Haddad E, Kenny GP, Wells GA et al (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286(10):1218–1227
Boule NG, Kenny GP, Haddad E, Wells GA et al (2003) Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46(8):1071–1081
Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2014) Therapie des Typ-2-Diabetes – Leitlinien-Report. Nationale VersorgungsLeitlinie 1. Auflage (Version 3. 2014, zuletzt verändert: Februar 2015.). https://doi.org/10.6101/azq/000226
Crawford P (2009) Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 22(5):507–512
Deutsche Adipositas-Gesellschaft (DAG) e. V. Deutsche Diabetes Gesellschaft (DDG), Deutsche Gesellschaft für Ernährung (DGE) e. V. DGfED (2014) Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“ Version 2.0
Du YZ, Gao XX, Wang CT, Zheng HZ, Lei Y, Wu MH, Shi XM, Ban HP, Gu WL, Meng XG, Wei MT, HC X (2017) Acupuncture lowering blood pressure for secondary prevention of stroke: a study protocol for a multicenter randomized controlled trial. Trials 18(1):428
DuBroff R, Lad V, CM-K (2015) A Prospective Trial of Ayurveda for Coronary Heart Disease: A Pilot Study. Altern Ther Health Med 21:52–62
Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A, Wedel N (2010) The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc 110(12):1852–1889
Gaede P, Lund-Andersen H, Parving H et al (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358(6):580–591
Hartley L, Lee MS, Kwong JS, Flowers N, Todkill D, Ernst E, Rees K (2015) Qigong for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 6 (CD010390)
Hartley L, Dyakova M, Holmes J, Clarke A, Lee MS, Ernst E, Rees K (2014a) Yoga for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 5 (CD010072)
Hartley L, Flowers N, Lee MS, Ernst E, Rees K (2014b) Tai chi for primary prevention of cardiovascular disease. Cochrane Database Syst Rev 4 (CD010366)
Hartley L, Mavrodaris A, Flowers N, Ernst E, Rees K (2014c) Transcendental meditation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 12 (CD010359)
Khan A, Safdar M, li Khan MM, Khattak K et al (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215–3218
Levine G. N. LRA, Bairey-Merz CN, Davidson RJ, Jamerson K, Mehta PK, Michos ED, Norris K, Ray IB, Saban KL, Shah T, Stein R, Jr; SSC, Cardiology; AHACoC, Nursing; CoCaS, Hypertension. aCo (2017) Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc 6(10):pii: e002218
Longhurst JC, C. T-A-LS (2017) Evidence-based blood pressure reducing actions of electroacupuncture: mechanisms and clinical application. Sheng Li Xue Bao 69(5):587–597
Look Ahead Research Group; Pi-Sunyer X et al; TLAR (2007) Reduction in Weight and Cardiovaskular Disease Risk Factors in Individuals with Type 2 Diabetes. Diabetes Care 30:1374–1383
Look Ahead Research Group; Wing RR; TLAR (2010) Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus. Four-Year Results of the Look AHEAD Trial. Arch Intern Med 170(17):1566–1575
Look Ahead Research Group; Wing RR (2013) Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes. N Engl J Med 369:145–154
Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, A. H (2006) Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36(5):340–344
Nielsen PJ, Hafdahl AR, Conn VS, Lemaster JW, A. BS (2006) Meta-analysis of the effect of exercise interventions on fitness outcomes among adults with type 1 and type 2 diabetes. Diabetes Res Clin Pract 74(2):111–120
Sahebkar A, Pirro M, Banach M, Mikhailidis DP, Atkin SL, G. CAF (2017) Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Crit Rev Food Sci Nutr Jun 13: 1–8. https://doi.org/10.1080/10408398.2017.1332572
Scherbaum WA, Haak T, Halle M, Kemmer FW, Stumvoll M, Thurm U, P. Z (2008) Körperliche Aktivität und Diabetes mellitus. Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft
Sivasankaran S, Pollard-Quintner S, Sachdeva R, Pugeda J, Hoq SM, W. ZS (2006) The effect of a six-week program of yoga and meditation on brachial artery reactivity: do psychosocial interventions affect vascular tone. Clin Cardiol 29:393–398
Snowling NJ, G. HW (2006) Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 29(11):2518–2527
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda MT, Group J-DS K (2017) Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol Oct 24: pii: S2213–8587 (2217)30327–30323. https://doi.org/10.1016/s2213-8587 (17)30327–3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Sulaj, A., Zemva, J. (2018). Fall 69: Prävention – 49 Jahre, ♀, DM Typ 2, Senkung des kardiovaskulären Risikos. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_69
Download citation
DOI: https://doi.org/10.1007/978-3-662-55972-7_69
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55971-0
Online ISBN: 978-3-662-55972-7
eBook Packages: Medicine (German Language)